US 2019/0167568 A1 · Transdermal Drug Delivery System and Method for Using Same

Abstract

[PROBLEMS TO BE SOLVED] To provide a method of advantageously improving a transdermal permeation amount of a steroid drug to diseased portions when treating ophthalmic diseases such as chalazion, blepharitis, allergic conjunctivitis, vernal keratoconjunctivitis, and meibomian gland dysfunction. [SOLUTION] To provide the transdermal drug delivery system for administering a drug via the eyelid skins that have been treated with a microneedle array, featured in that the drug is a water-soluble steroid, and the transdermal drug delivery system is a water-containing base adhesive skin patch.

Claims14

Dependent claims

A transdermal drug delivery system for administering a drug for treating ophthalmic diseases via an eyelid skin that has been treated by a microneedle array, wherein

the drug is a water-soluble steroid, and
the transdermal drug delivery system is a water-containing base adhesive skin patch.

Dependencies are inferred from the claim text.

Facts

Application

16/313,739Filed 29 Jun 2017

Priority

29 Jun 2016

Published

6 Jun 2019

Term ends

Not estimatedThe source records don’t support an estimate.

Classification13 codes

A61K 9/0014
Galenical forms characterised by the site of application: skin, i.e. galenical aspects of topical compositions
A61K 9/7061
Obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene: polyacrylates
A61K 31/573
Substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone: substituted in position 21, e.g. cortisone,…
A61M 37/00
Devices for delivering substances into the body: other apparatus for introducing media

Transdermal Drug Delivery System and Method for Using Same

Life of this patent

Transdermal Drug Delivery System and Method for Using Same

Life of this patent

Abstract

Claims14